0001815624-21-000002.txt : 20210429 0001815624-21-000002.hdr.sgml : 20210429 20210429110639 ACCESSION NUMBER: 0001815624-21-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210429 DATE AS OF CHANGE: 20210429 EFFECTIVENESS DATE: 20210429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GelMEDIX, Inc. CENTRAL INDEX KEY: 0001815624 IRS NUMBER: 881188838 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-369335 FILM NUMBER: 21868130 BUSINESS ADDRESS: STREET 1: 90 BRIDGE STREET CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: 617-500-3455 MAIL ADDRESS: STREET 1: 90 BRIDGE STREET CITY: NEWTON STATE: MA ZIP: 02458 D/A 1 primary_doc.xml X0708 D/A LIVE 0001815624 GelMEDIX, Inc. 90 BRIDGE STREET NEWTON MA MASSACHUSETTS 02458 617-500-3455 DELAWARE None None Corporation true 2020 Reza Dana c/o GelMEDIX, Inc. 90 Bridge Street Newton MA MASSACHUSETTS 02458 Director Nasim Annabi c/o GelMEDIX, Inc. 90 Bridge Street Newton MA MASSACHUSETTS 02458 Director Jeffrey Behrens c/o GelMEDIX, Inc. 90 Bridge Street Newton MA MASSACHUSETTS 02458 Executive Officer Director Biotechnology Decline to Disclose 06b true 0001815624-20-000001 2020-06-04 false true true false 0 5000000 2600000 2400000 false 4 0 0 0 false GelMEDIX, Inc. /s/ Jeffrey Behrens Jeffrey Behrens Chief Executive Officer 2021-04-28